SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-23-082264
Filing Date
2023-03-28
Accepted
2023-03-28 16:44:49
Documents
144
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 20-F d430075d20f.htm   iXBRL 20-F 4032905
2 EX-2.2 d430075dex22.htm EX-2.2 141944
3 EX-4.17 d430075dex417.htm EX-4.17 83570
4 EX-4.46 d430075dex446.htm EX-4.46 38404
5 EX-4.47 d430075dex447.htm EX-4.47 157182
6 EX-8.1 d430075dex81.htm EX-8.1 3627
7 EX-12.1 d430075dex121.htm EX-12.1 10482
8 EX-12.2 d430075dex122.htm EX-12.2 10450
9 EX-13.1 d430075dex131.htm EX-13.1 2952
10 EX-13.2 d430075dex132.htm EX-13.2 2921
11 EX-15.1 d430075dex151.htm EX-15.1 2096
12 EX-15.2 d430075dex152.htm EX-15.2 6708
18 GRAPHIC g430075page16.jpg GRAPHIC 222904
  Complete submission text file 0001193125-23-082264.txt   17132274

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA mreo-20221231.xsd EX-101.SCH 143188
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mreo-20221231_cal.xml EX-101.CAL 58770
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mreo-20221231_def.xml EX-101.DEF 507979
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE mreo-20221231_lab.xml EX-101.LAB 763183
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mreo-20221231_pre.xml EX-101.PRE 691065
138 EXTRACTED XBRL INSTANCE DOCUMENT d430075d20f_htm.xml XML 3392192
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Filer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-38452 | Film No.: 23770186
SIC: 2834 Pharmaceutical Preparations